Enzolytics Inc (ENZC)

[Timing101]

Added today .. hard work took awhile .... so the core position is SOLID and LOCKED.. (do not want any shorties on those other brokers that allow it (mine does not) to "borrow' any shares.. squeeze them folks .. lock your shares.
--
The news today is VALIDATION and coming from Charles Cotropia directly is the KEY ...
--
https://www.otcmarkets.com/stock/ENZC/news/story?e&id=1717739
--
Note ..
OTC update state this WEEK not in the upcoming week(s) ... Harry has been given a TASK and knows that this is his time if it ever was to live up to the Patents and his Fathers work over decades of time in his own Medical Research efforts.
--
Quote
"We will keep you up to date on our progress. We extend our sincere appreciation for your support.

Best regards,

Charles Cotropia
CEO
BioClonetics Immunotherapeutics, Inc."

The proposed merger anticipated in the recently announced binding LOI will result in Charles Cotropia being appointed as CEO of the merged entity and Harry Zhabilov and Joseph Cotropia, MD, being appointed as co-CSO. Gaurav Chandra, MD, will serve as COO of the merged entity. Charles Cotropia was appointed to the ENZC Board of Directors on October 1, 2020. Simultaneously, Harry Zhabilov was appointed to the BCLS board on October 1, 2020.

Enzolytics anticipates a response on the application recently made at OTC Markets in the coming week and will begin bringing their filings current, immediately upon membership. In addition, management of ENZC is scheduling a meeting with a GMP manufacturer before the end of the month.